NEWS & INSIGHTS

FROM EXCEPTIONAL SURVIVORS TO NEW CANCER DISCOVERIES

Follow the research, people and milestones behind our mission to understand why some patients survive against the odds.

NEWS & INSIGHTS

FROM EXCEPTIONAL SURVIVORS TO NEW CANCER DISCOVERIES

Follow the research, people and milestones behind our mission to understand why some patients survive against the odds.

NEWS & INSIGHTS

FROM EXCEPTIONAL SURVIVORS TO NEW CANCER DISCOVERIES

Follow the research, people and milestones behind our mission to understand why some patients survive against the odds.

The science

Explore the biology, multi-omics and AI behind our research.

Biology | Multi-omics | Rosalind Study | Drug Discovery

The science

Explore the biology, multi-omics and AI behind our research.

Biology | Multi-omics | Rosalind Study | Drug Discovery

Inside Cure51

Our milestones, our progress.

Milestones | Insights | The people behind the research

Inside Cure51

Our milestones, our progress.

Milestones | Insights | The people behind the research

KEY NUMBERS

Expanding the boundaries of cancer research

→ Creating a community of

+100

+100

patients

→ Gathering a network of

+0

+0

CENTERS

→ Collaboration in

10

10

Countries

→ Focusing on

1

1

INDICATIONS: PDAC, GBM & SCLC

KEY NUMBERS

Expanding the boundaries of cancer research

→ Creating a community of

+100

+100

patients

→ Gathering a network of

+0

+0

CENTERS

→ Collaboration in

10

10

Countries

→ Focusing on

1

1

INDICATIONS: PDAC, GBM & SCLC

The network

Discover our collaborations with leading oncology centers from all around the world.

International oncology network | Rosalind Study

The network

Discover our collaborations with leading oncology centers from all around the world.

International oncology network | Rosalind Study

The network

Discover our collaborations with leading oncology centers from all around the world.

International oncology network | Rosalind Study

Glioblastoma

Understand how we accelerate glioblastoma research.

GBM | Servier | Target Discovery | Target Identification

Glioblastoma

Understand how we accelerate glioblastoma research.

GBM | Servier | Target Discovery | Target Identification

Glioblastoma

Understand how we accelerate glioblastoma research.

GBM | Servier | Target Discovery | Target Identification

The patients

Meet the exceptional survivors who inspire our mission.

Exceptional cancer survivors | Patient Committee | Advocates

The patients

Meet the exceptional survivors who inspire our mission.

Exceptional cancer survivors | Patient Committee | Advocates

The patients

Meet the exceptional survivors who inspire our mission.

Exceptional cancer survivors | Patient Committee | Advocates

UNTIL ALL SURVIVE.

From frontline caregivers and patients to researchers and media voices, we bring diverse perspectives together to advance cancer research. Let’s talk.

UNTIL ALL SURVIVE.

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.

©2024 Cure51, All Rights Reserved

©2026 Cure51, All Rights Reserved

Rosalind is an independent, proprietary Cure51 clinical study and is not affiliated with any external AI models or products.